Product Details

Full Product Name

Rabbit anti-Homo sapiens (Human) DYRK2 Polyclonal antibody

Uniprot No.

Q92630

Target Names

DYRK2

Alternative Names

1810038L18Rik antibody; Dual specificity tyrosine (Y) phosphorylation regulated kinase 2 antibody; Dual specificity tyrosine phosphorylation regulated kinase 2 antibody; Dual specificity tyrosine-phosphorylation-regulated kinase 2 antibody; DYRK2 antibody; DYRK2_HUMAN antibody; EC 2.7.12.1 antibody; FLJ21217 antibody; FLJ21365 antibody

Raised in

Rabbit

Species Reactivity

Human

Immunogen

Recombinant Human Dual specificity tyrosine-phosphorylation-regulated kinase 2 protein (502-601AA)

Immunogen Species

Homo sapiens (Human)

Conjugate

Non-conjugated

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Form

Liquid

Tested Applications

ELISA, IHC

Recommended Dilution

Application	Recommended Dilution
IHC	1:20-1:200

Protocols

ELISA Protocol
Immunohistochemistry (IHC) Protocol

Troubleshooting and FAQs

Antibody FAQs

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Lead Time

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Usage

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Target Background

Function

Serine/threonine-protein kinase involved in the regulation of the mitotic cell cycle, cell proliferation, apoptosis, organization of the cytoskeleton and neurite outgrowth. Functions in part via its role in ubiquitin-dependent proteasomal protein degradation. Functions downstream of ATM and phosphorylates p53/TP53 at 'Ser-46', and thereby contributes to the induction of apoptosis in response to DNA damage. Phosphorylates NFATC1, and thereby inhibits its accumulation in the nucleus and its transcription factor activity. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3B. Likewise, phosphorylation of NFATC1, CRMP2/DPYSL2 and CRMP4/DPYSL3 promotes their subsequent phosphorylation by GSK3B. May play a general role in the priming of GSK3 substrates. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of KATNA1. Phosphorylates TERT at 'Ser-457', promoting TERT ubiquitination by the EDVP complex. Phosphorylates SIAH2, and thereby increases its ubiquitin ligase activity. Promotes the proteasomal degradation of MYC and JUN, and thereby regulates progress through the mitotic cell cycle and cell proliferation. Promotes proteasomal degradation of GLI2 and GLI3, and thereby plays a role in smoothened and sonic hedgehog signaling. Plays a role in cytoskeleton organization and neurite outgrowth via its phosphorylation of DCX and DPYSL2. Phosphorylates CRMP2/DPYSL2, CRMP4/DPYSL3, DCX, EIF2B5, EIF4EBP1, GLI2, GLI3, GYS1, JUN, MDM2, MYC, NFATC1, p53/TP53, TAU/MAPT and KATNA1. Can phosphorylate histone H1, histone H3 and histone H2B (in vitro). Can phosphorylate CARHSP1 (in vitro).

Gene References into Functions

The expression level of DYRK2 was positively correlated with glioma pathological grade. PMID: 28677030
Results provide evidence that DYRK2 suppresses the proliferation of breast cancer cells and invasion through CDK14 expression. PMID: 29193658
Study found that DYRK2 regulates liver metastases of colorectal cancer cells through the activation of EMT, and that patients with low DYRK2-expressing colorectal cancer liver metastases had worse outcomes than those with high DYRK2-expressing metastases. PMID: 28502078
our results delineate a novel mechanism of cancer stem cell regulation by the DYRK2-AR-KLF4 axis. Restoration of the expression and function of DYRK2 is a potential therapeutic strategy against breast cancer stem cells. PMID: 27721402
lower DYRK2 levels were correlated with tumor sites, advanced clinical stages, and shorter survival in the advanced clinical stages. DYRK2 is a novel prognostic biomarker of human colorectal cancer. PMID: 27532268
Diminished DYRK2 expression sensitizes hormone receptor-positive breast cancer to everolimus by preventing mTOR degradation. PMID: 27746162
Findings indicate direct interaction of dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) with ring finger protein (C3HC4 type) 8 (RNF8) in regulating response to DNA damage. PMID: 28194753
the downregulated expression of DYRK2 in HCC tumor tissues could promote the proliferation of hepatocellular carcinoma (HCC) cells. In addition, reducing DYRK2 expression was associated with poor prognosis and Oxaliplatin resistance in HCC. PMID: 26804244
Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma PMID: 26341817
DYRK2 may regulate EMT through Snail degradation in ovarian SA and might be a predictive marker for a favorable prognosis in the treatment of this cancer. PMID: 25712377
Downregulation of DYRK2 is associated with recurrence in early stage breast cancer. PMID: 25095982
DYRK2-dependent phosphorylation of pregnane X receptor facilitates its subsequent ubiquitination by UBR5. PMID: 24438055
DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail. PMID: 23791882
DYRK2-mediated phosphorylation of p53 at Ser46 is impaired under hypoxic conditions, suggesting a molecular mechanism underlying chemotherapy resistance in solid tumors. PMID: 22878263
Data indicate that Dyrk2 phosphorylates TERT protein, which is then associated with the EDD-DDB1-VprBP E3 ligase complex for subsequent ubiquitin-mediated TERT protein degradation. PMID: 23362280
DYRK2 regulates tumor progression through modulation of c-Jun and c-Myc PMID: 22307329
The findings indicate that ATM controls stability and pro-apoptotic function of DYRK2 in response to DNA damage. PMID: 19965871
These findings indicate that DYRK2 regulates p53 to induce apoptosis in response to DNA damage. PMID: 17349958
A protein kinase, DYRK2, has unexpected role as a scaffold for an E3 ubiquitin ligase complex. PMID: 19287380
disease control rate of the DYRK2-positive non-small cell lung cancer patients was significantly different from the DYRK2-negative group PMID: 19596956
The data showed that DYRK2 expression is associated with a favorable prognosis in pulmonary adenocarcinoma. PMID: 19818968

Hide All

Subcellular Location

Cytoplasm. Nucleus. Note=Translocates into the nucleus following DNA damage.

Protein Families

Protein kinase superfamily, CMGC Ser/Thr protein kinase family, MNB/DYRK subfamily

Tissue Specificity

Testis, after the onset of spermatogenesis.

Database Links

HGNC: 3093

OMIM: 603496

KEGG: hsa:8445

STRING: 9606.ENSP00000342105

UniGene: Hs.173135

Message

Product >> Product Name：
Product >> Code：
Name： *
Email： *
Company/Organization：
Phone：
Since emails may get flagged by spam filters occasionally, we recommend leaving your phone number as a precaution. Your information is safe with us.
Question/Comment： *
Your Region： *
I'd like to receive email newsletters from Cusabio

Yes

No
How do you know CUSABIO?

Email

Distributor

Search engine

Advertisement

Others
CAPTCHA verification：
If CAPTCHA verification fails, click to refresh the CAPTCHA and try again.

Code	CSB-PA852896ESR1HU
Size	US$166
	Order now
Image	Immunohistochemistry of paraffin-embedded human breast cancer using CSB-PA852896ESR1HU at dilution of 1:100 Immunohistochemistry of paraffin-embedded human testis tissue using CSB-PA852896ESR1HU at dilution of 1:100
Have Questions?	Leave a Message or Start an on-line Chat

DYRK2 Antibody

Product Details

Related Products

Customer Reviews and Q&A

Target Background